Edward M. Kaye
2021 - Stoke Therapeutics
In 2021, Edward M. Kaye earned a total compensation of $8.5M as Chief Executive Officer at Stoke Therapeutics.
Compensation breakdown
| Bonus | $15,612 |
|---|---|
| Non-Equity Incentive Plan | $343,458 |
| Option Awards | $7,604,990 |
| Salary | $567,698 |
| Other | $11,600 |
| Total | $8,543,358 |
Kaye received $7.6M in option awards, accounting for 89% of the total pay in 2021.
Kaye also received $15.6K in bonus, $343.5K in non-equity incentive plan, $567.7K in salary and $11.6K in other compensation.
Rankings
In 2021, Edward M. Kaye's compensation ranked 1,320th out of 12,415 executives tracked by ExecPay. In other words, Kaye earned more than 89.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,320 out of 12,415 | 89th |
Division Manufacturing | 470 out of 5,501 | 92nd |
Major group Chemicals And Allied Products | 170 out of 2,371 | 93rd |
Industry group Drugs | 142 out of 2,092 | 93rd |
Industry Pharmaceutical Preparations | 93 out of 1,542 | 94th |
Source: SEC filing on April 27, 2023.
Kaye's colleagues
We found two more compensation records of executives who worked with Edward M. Kaye at Stoke Therapeutics in 2021.